Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy

Macrophage inhibitory factor 1 (MIC1) is frequently altered in various cancers. The aim of this study was to investigate the clinical significance of MIC1 for esophageal squamous cell carcinoma (ESCC). Serum MIC1 of 286 ESCC and 250 healthy subjects was detected, the diagnostic performance was asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiao-Bing, Jiang, Xing-Ran, Yu, Xi-Ying, Wang, Lin, He, Shun, Feng, Fei-Yue, Guo, Li-Ping, Jiang, Wei, Lu, Shih-Hsin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317821/
https://www.ncbi.nlm.nih.gov/pubmed/24383865
http://dx.doi.org/10.1111/cas.12331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317821/
https://www.ncbi.nlm.nih.gov/pubmed/24383865
http://dx.doi.org/10.1111/cas.12331

Ejemplares similares